4.4362
X 4 Pharmaceuticals Inc (XFOR) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
93.78%
1.744
|
0.90 | 1.434 | 0.56 | 0.563 |
Cost Of Revenue |
93.09%
0.326
|
4.716 | 0.302 | 0.227 | 0.268 |
Gross Profit |
137.16%
1.418
|
-3.816 | 1.132 | 0.333 | 0.295 |
|
391.38%
27.65
|
5.627 | 36.85 | 34.83 | -70.81 |
Benefits Costs and Expenses |
4,600%
27.45
|
0.584 | 41.00 | 37.24 | -90.29 |
Costs And Expenses |
4,600%
27.45
|
0.584 | 40.26 | 37.24 | -90.29 |
Operating Income/Loss |
177.79%
-26.23
|
-9.443 | -35.72 | -34.50 | 71.10 |
Nonoperating Income/Loss |
94.59%
0.528
|
9.759 | -3.848 | -2.181 | 19.75 |
Income/Loss From Continuing Operations Before Tax |
8,234%
-25.70
|
0.316 | -39.56 | -36.68 | 90.85 |
Income Tax Expense/Benefit |
8.82%
0.037
|
0.034 | 0.258 | 0.015 | 0.018 |
Income/Loss From Continuing Operations After Tax |
9,228%
-25.74
|
0.282 | -39.82 | -36.70 | 90.83 |
|
9,228%
-25.74
|
0.282 | -39.82 | -36.70 | 90.83 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
8.38%
7.413
|
6.84 | 0.6282 | 200.87 | 200.44 |
Diluted Average Shares |
7.92%
7.413
|
6.8691 | 0.451 | 200.87 | 200.80 |
Basic Earnings Per Share |
8,775%
-3.47
|
0.04 | -0.20 | -0.18 | 0.45 |
Diluted Earnings Per Share |
8,775%
-3.47
|
0.04 | -0.20 | -0.18 | 0.45 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):